Risikomerkmale und Überlebensrate des malignen Melanoms in Deutschland und den Niederlanden
Standard
Risikomerkmale und Überlebensrate des malignen Melanoms in Deutschland und den Niederlanden. / Augustin, J; Schäfer, I; Reusch, M; Augustin, M.
In: HAUTARZT, Vol. 67, No. 12, 12.2016, p. 996-1002.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Risikomerkmale und Überlebensrate des malignen Melanoms in Deutschland und den Niederlanden
AU - Augustin, J
AU - Schäfer, I
AU - Reusch, M
AU - Augustin, M
N1 - Es besteht eine enge Kooperation zwischen dem IStAD und dem IVDP; die Studie wurde am IVDP durchgeführt.
PY - 2016/12
Y1 - 2016/12
N2 - BACKGROUND: Mortality and lethality of malignant melanoma (MM) show marked variations throughout Europe, thereunder a higher risk within the Netherlands (NL) when compared to Germany (D).GOAL AND METHODS: Comparison of systems and exploration of possible causal factors that could explain the difference between D and NL. Comparative healthcare research analysis using published international literature, as well as publicly accessible databases, and a subsequent hypothesis-generating analysis.RESULTS: The higher rate of excised MM less than 1 mm in diameter in D (65 % vs. 45 %) confirms the clinical reports of the cancer registries. The biological factors for the emergence of MM, such as skin type, do not seem to significantly differ from each other. Among the further potential predictors there are no relevant differences within, for example, geographical conditions and the qualifications of the treating physicians. Primary prevention has a longer continual tradition in D. Here, secondary prevention is characterized by population-based extensive screening, which does not occur within the NL. In addition, distinct differences are found regarding access to dermatologists.CONCLUSION: System access to a medical specialist and the prevention of skin cancer are currently the most distinctive potential determinants of more favorable MM survival rate in Germany.
AB - BACKGROUND: Mortality and lethality of malignant melanoma (MM) show marked variations throughout Europe, thereunder a higher risk within the Netherlands (NL) when compared to Germany (D).GOAL AND METHODS: Comparison of systems and exploration of possible causal factors that could explain the difference between D and NL. Comparative healthcare research analysis using published international literature, as well as publicly accessible databases, and a subsequent hypothesis-generating analysis.RESULTS: The higher rate of excised MM less than 1 mm in diameter in D (65 % vs. 45 %) confirms the clinical reports of the cancer registries. The biological factors for the emergence of MM, such as skin type, do not seem to significantly differ from each other. Among the further potential predictors there are no relevant differences within, for example, geographical conditions and the qualifications of the treating physicians. Primary prevention has a longer continual tradition in D. Here, secondary prevention is characterized by population-based extensive screening, which does not occur within the NL. In addition, distinct differences are found regarding access to dermatologists.CONCLUSION: System access to a medical specialist and the prevention of skin cancer are currently the most distinctive potential determinants of more favorable MM survival rate in Germany.
U2 - 10.1007/s00105-016-3876-1
DO - 10.1007/s00105-016-3876-1
M3 - SCORING: Zeitschriftenaufsatz
C2 - 27654827
VL - 67
SP - 996
EP - 1002
JO - HAUTARZT
JF - HAUTARZT
SN - 0017-8470
IS - 12
ER -
